Cover Image
Market Research Report

In-Vitro Diagnostics Market Global Report 2017 - Including Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology

Published by The Business Research Company Product code 531344
Published Content info 250 Pages
Delivery time: 1-2 business days
Price
Back to Top
In-Vitro Diagnostics Market Global Report 2017 - Including Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology
Published: July 17, 2017 Content info: 250 Pages
Description

In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person's state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids.

The In-Vitro Diagnostics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.

Where is the largest and fastest growing market for the In-vitro diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider medical equipment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The In-vitro diagnostics market section of the report gives context. It compares the In-vitro diagnostics market with other segments of the medical equipment market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope:

Markets Covered: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology

Companies Mentioned: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents

Table of Contents

1. In-Vitro Diagnostics Market Characteristics

2. In-Vitro Diagnostics Market Size And Growth

  • 2.1. Historic Market Growth
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Pestle Analysis

  • 3.1. Political
  • 3.2. Economic
  • 3.3. Social
  • 3.4. Technological
  • 3.5. Legal
  • 3.6. Environmental

4. In-Vitro Diagnostics Market Customer Information

5. In-Vitro Diagnostics Market Segmentation

  • 5.1. Global In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
  • 5.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Segment
  • 5.3 Global In-Vitro Diagnostics Market Trends And Strategies; Strategic Collaborations And Agreements; New Product Launches; Rising Demand for Point-of-Care (POC) Testing
  • 5.4 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016
  • 5.5 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012 - 2020, Historic and Forecast
  • 5.6 In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region
  • 5.7. In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country
  • 5.8 Point-Of-Care Diagnostics
    • 5.8.1 Market Characteristics
    • 5.8.2. Global Point-Of-Care Diagnostics Market, 2016, By Segment
    • 5.8.3. Market Trends And Strategies
  • 5.9 Immunochemistry
    • 5.9.1. Market Characteristics
    • 5.9.2. Global Immunochemistry Market, 2016, By Segment
    • 5.9.3. Market Trends And Strategies
  • 5.10 Clinical Chemistry
    • 5.10.1. Market Characteristics
    • 5.10.2. Global Clinical Chemistry Market, 2016, By Segment
    • 5.10.3. Market Trends And Strategies
  • 5.11 Molecular Diagnostics
    • 5.11.1. Market Characteristics
    • 5.11.2. Global Molecular Diagnostics Market, 2016, By Segment
    • 5.11.3. Market Trends And Strategies
  • 5.12 Microbiology
    • 5.12.1. Market Characteristics
    • 5.12.2. Global Microbiology Market, 2016, By Segment
    • 5.12.3. Market Trends And Strategies
  • 5.13 Hemostasis
    • 5.13.1. Market Characteristics
    • 5.13.2. Global Hemostasis Market, 2016, By Segment
    • 5.13.3. Market Trends And Strategies
  • 5.14 Hematology And Immunohematology
    • 5.14.1. Market Characteristics
    • 5.14.2. Global Hematology And Immunohematology Market, 2016, By Segment
    • 5.14.3. Market Trends And Strategies

6. In-Vitro Diagnostics Market Regional And Country Analysis

  • 6.1. Global In-Vitro Diagnostics Market, 2016, By Region
  • 6.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Region
  • 6.3. In-Vitro Diagnostics Market, 2016, By Country
  • 6.4. In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Country
  • 6.5. Global Healthcare Market Segments, 2016, By Region
  • 6.6. Global Medical Equipment Market Segments, 2016, By Region
  • 6.7. Global Healthcare Market Segments, 2016, By Country
  • 6.8. Global Medical Equipment Market Segments, 2016, By Country

7. Global In-Vitro Diagnostics Market Comparison With Macro Economic Factors

  • 7.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, Global
  • 7.2. Per Capita Average In-Vitro Diagnostics Expenditure, Global

8. In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries

  • 8.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country
  • 8.2. Per Capita Average In-Vitro Diagnostics Expenditure, By Country

9. In-Vitro Diagnostics Market Comparison With Industry Metrics

  • 9.1. Global Number Of Medical Labs, 2016, By Country
  • 9.2. Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country

10. Asia-Pacific In-Vitro Diagnostics Market

    • 10.1.1. Asia-Pacific In-Vitro Diagnostics Market Overview
    • 10.1.2. Asia-Pacific In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 10.1.3. Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 10.1.4. Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
  • 10.2. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis
  • 10.3. China In-Vitro Diagnostics Market
    • 10.3.1. China In-Vitro Diagnostics Market Overview
    • 10.3.2. China In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 10.3.3. China In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 10.3.4. China In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 10.3.5. China In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 10.3.6. China Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 10.4. India In-Vitro Diagnostics Market
    • 10.4.1. India In-Vitro Diagnostics Market Overview
    • 10.4.2. India In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 10.4.3. India In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 10.4.4. India In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 10.4.5. India In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 10.4.6. India Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 10.5. Japan In-Vitro Diagnostics Market
    • 10.5.1. Japan In-Vitro Diagnostics Market Overview
    • 10.5.2. Japan In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 10.5.3. Japan In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 10.5.4. Japan In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 10.5.5. Japan In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 10.5.6. Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 10.6. Australia In-Vitro Diagnostics Market
    • 10.6.1. Australia In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 10.6.2. Australia In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 10.6.3. Australia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 10.6.4. Australia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 10.6.5. Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020

11. Western Europe In-Vitro Diagnostics Market

    • 11.1.1. Western Europe In-Vitro Diagnostics Market Overview
    • 11.1.2. Western Europe In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.1.3. Western Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.1.4. Western Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
  • 11.2. Western Europe In-Vitro Diagnostics Market: Country Analysis
  • 11.3. UK In-Vitro Diagnostics Market
    • 11.3.1. UK In-Vitro Diagnostics Market Overview
    • 11.3.2. UK In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.3.3. UK In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.3.4. UK In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 11.3.5. UK In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 11.3.6. UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 11.4. Germany In-Vitro Diagnostics Market
    • 11.4.1. Germany In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.4.2. Germany In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.4.3. Germany In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 11.4.4 Germany In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 11.4.5 Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 11.5 France In-Vitro Diagnostics Market
    • 11.5.1 France In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.5.2 France In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.5.3 France In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 11.5.4 France In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 11.5.5 France Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 11.6. Italy In-Vitro Diagnostics Market
    • 11.6.1. Italy In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.6.2. Italy In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.6.3. Italy In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 11.6.4. Italy In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 11.6.5. Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
  • 11.7. Spain In-Vitro Diagnostics Market
    • 11.7.1. Spain In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 11.7.2. Spain In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 11.7.3. Spain In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 11.7.4. Spain In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 11.7.5. Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020

12. Eastern Europe In-Vitro Diagnostics Market

    • 12.1.1. Eastern Europe In-Vitro Diagnostics Market Overview
    • 12.1.2. Eastern Europe In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 12.1.3. Eastern Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 12.1.4 Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
  • 12.2. Eastern Europe In-Vitro Diagnostics Market: Country Analysis
  • 12.3. Russia In-Vitro Diagnostics Market
    • 12.3.1. Russia In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 12.3.2. Russia In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 12.3.3. Russia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 12.3.4. Russia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 12.3.5. Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020

13. North America In-Vitro Diagnostics Market

    • 13.1.1. North America In-Vitro Diagnostics Market Overview
    • 13.1.2. North America In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 13.1.3. North America In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 13.1.4. North America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis
  • 13.2. North America In-Vitro Diagnostics Market: Country Analysis
  • 13.3. USA In-Vitro Diagnostics Market
    • 13.3.1. USA In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 13.3.2. USA In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 13.3.3 USA In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 13.3.4. USA In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 13.3.5. USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020

14. South America In-Vitro Diagnostics Market

    • 14.1.1. South America In-Vitro Diagnostics Market Overview
    • 14.1.2. South America In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 14.1.3. South America In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 14.1.4. South America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
  • 14.2. South America In-Vitro Diagnostics Market: Country Analysis
  • 14.3. Brazil In-Vitro Diagnostics Market
    • 14.3.1. Brazil In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 14.3.2. Brazil In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 14.3.3. Brazil In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology
    • 14.3.4. Brazil In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
    • 14.3.5. Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020

15. Middle East In-Vitro Diagnostics Market

    • 15.1.1. Middle East In-Vitro Diagnostics Market Overview
    • 15.1.2. Middle East In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 15.1.3. Middle East In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 15.1.4. Middle East In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology

16. Africa In-Vitro Diagnostics Market

    • 16.1.1. Africa In-Vitro Diagnostics Market Overview
    • 16.1.2. Africa In-Vitro Diagnostics Historic Market, 2012 - 2016
    • 16.1.3. Africa In-Vitro Diagnostics Forecast Market, 2016 - 2020
    • 16.1.4. Africa In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology

17. In-Vitro Diagnostics Market Competitive Landscape

  • 17.1. Company Profiles
  • 17.2. F. Hoffmann-La Roche Ltd
    • 17.2.1. Overview
    • 17.2.2. Products And Services
    • 17.2.3. Strategy
    • 17.2.4. Financial Performance
  • 17.3. Siemens Healthineers
    • 17.3.1. Overview
    • 17.3.2. Products And Services
    • 17.3.3. Strategy
    • 17.3.4. Financial Performance
  • 17.4. Danaher (Beckman Coulter Inc)
    • 17.4.1. Overview
    • 17.4.2. Products And Services
    • 17.4.3. Strategy
    • 17.4.4. Financial Performance
  • 17.5. Abbott Laboratories Inc.
    • 17.5.1. Overview
    • 17.5.2. Products And Services
    • 17.5.3. Strategy
    • 17.5.4. Financial Performance
  • 17.6. Thermo Fisher Scientific
    • 17.6.1. Overview
    • 17.6.2. Products And Services
    • 17.6.3. Strategy
    • 17.6.4. Financial Performance

18. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market

19. Market Background: Medical Equipment Market

    • 19.1.1. Medical Equipment Market Characteristics
    • 19.1.2. Medical Equipment Market Historic Growth
      • 19.1.2.1. Drivers Of The Market
      • 19.1.2.2. Restraints Of The Market
    • 19.1.3. Medical Equipment Market Forecast Growth
      • 19.1.3.1. Drivers Of The Market
      • 19.1.3.2. Restraints Of The Market
    • 19.1.4. Medical Equipment Trends And Strategies
  • 19.2. Medical Equipment Market Regional And Country Analysis
    • 19.2.1. Global Medical Equipment Market, 2016, By Region
    • 19.2.2. Global Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Region
    • 19.3.3. Medical Equipment Market, 2016, By Country
    • 19.2.4. Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Country
    • 19.2.5. Global Medical Equipment Market, Growth And Market Share Comparison, By Segment
    • 19.2.6. Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment
  • 19.3. Global Medical Equipment Market Comparison With Macro Economic Factors
    • 19.3.1. Medical Equipment Market Size, Percentage Of GDP, Global
    • 19.3.2. Per Capita Average Medical Equipment Expenditure, Global
  • 19.4. Medical Equipment Market Comparison With Macro Economic Factors Across Countries
    • 19.4.1. Medical Equipment Market Size, Percentage Of GDP, By Country
    • 19.4.2. Per Capita Average Medical Equipment Expenditure, By Country
  • 19.5. Key Mergers And Acquisitions In The Medical Equipment Market

20. Healthcare Industry Financial Margins

21. Appendix

  • 21.1. NAICS Definitions Of Industry Covered In This Report
  • 21.2. Abbreviations
  • 21.3. Currencies
  • 21.4. Research Inquiries
  • 21.5. The Business Research Company
  • 21.6. Copyright And Disclaimer
Back to Top